Материалы доступны только для специалистов сферы здравоохранения.
Чтобы посмотреть материал полностью
Авторизуйтесь
или зарегистрируйтесь.
Хроническая тазовая боль – женская проблема
Хроническая тазовая боль – женская проблема
Кузнецова И.В. Хроническая тазовая боль – женская проблема. Гинекология. 2017; 19 (3): 62–67. DOI: 10.26442/2079-5696_19.3.62-67
________________________________________________
Материалы доступны только для специалистов сферы здравоохранения.
Чтобы посмотреть материал полностью
Авторизуйтесь
или зарегистрируйтесь.
Аннотация
Хроническая тазовая боль (ХТБ) встречается преимущественно у женщин и поэтому часто расценивается как симптом гинекологического заболевания. Между тем причины ХТБ обычно множественны, и ее формирование связано прежде всего с персистенцией эстрогензависимого воспаления и развитием периферической и центральной сенситизации нервной системы. Наличие эстрогензависимого воспаления объясняет, с одной стороны, женскую «привилегию» на боль, с другой – частое выявление эндометриоза у пациенток с ХТБ. В то же время актуализация проблемы ХТБ как главной цели лечения позволяет осуществить разумный выбор средств для улучшения качества жизни больных.
Ключевые слова: хроническая тазовая боль, эндометриоз, воспалительные заболевания органов таза, синдром тазовой конгестии, комбинированные оральные контрацептивы.
Key words: chronic pelvic pain, endometriosis, pelvic inflammatory diseases, pelvic lumbar syndrome, combined oral contraceptives.
Ключевые слова: хроническая тазовая боль, эндометриоз, воспалительные заболевания органов таза, синдром тазовой конгестии, комбинированные оральные контрацептивы.
________________________________________________
Key words: chronic pelvic pain, endometriosis, pelvic inflammatory diseases, pelvic lumbar syndrome, combined oral contraceptives.
Полный текст
Список литературы
1. Gunter J. Neurobiology of chronic pelvic pain. In: Chronic Pelvic Pain, ed. P.Vercellini; London, UK: Blackwell Publishing, 2011: 1–6.
2. Воробьева О.В. Хронические тазовые боли: фокус на миофасциальный болевой синдром мышц тазового дна. Consilium Medicum. 2012; 6 (14): 14–8. / Vorob'eva O.V. Khronicheskie tazovye boli: fokus na miofastsial'nyi bolevoi sindrom myshts tazovogo dna. Consilium Medicum. 2012; 6 (14): 14–8. [in Russian]
3. Адамян Л.В., Сухих Г.Т. Технологии XXI века в гинекологии. М.: Медиасфера, 2008; с. 248. / Adamian L.V., Sukhikh G.T. Tekhnologii XXI veka v ginekologii. M.: Mediasfera, 2008; s. 248. [in Russian]
4. Coosemans A, Moerman P, Vergote I et al. Wilm`s tumor gene 1(WT1) over expression in neurons in deep endometriosis: a pilot study. Fertil Steril 2009; 91 (4): 1441–4.
5. Giamberardino MA. Women and visceral pain: are the reproductive organs the main protagonists? Minireview at the occasion of the “European week against pain in women 2007”. Eur J Pain 2008; 12 (3): 257–60.
6. Wiech K, Tracey I. Influence of negative emotions on pain: behavioral effects and neural mechanisms. Neuroimage 2009; 47: 987–94.
7. Craig KD, Versloot J, Goubert L et al. Perceiving pain in others: automatic and controlled mechanisms. Pain 2010; 11 (2): 101–8.
8. Yarell J, Giamberardino MA, Robert M, Nasr-Esfabani M. Bed-side testing for chronic pelvic pain: discriminating visceral from somatic pain. Pain Res Treat 2011; 11: 692–8.
9. Адамян Л.В., Сонова М.М., Тихонова Е.С. и др. Медицинские и социальные аспекты генитального эндометриоза. Проблемы репродукции. 2011; 6: 78–81. / Adamian L.V., Sonova M.M., Tikhonova E.S. i dr. Meditsinskie i sotsial'nye aspekty genital'nogo endometrioza. Problemy reproduktsii. 2011; 6: 78–81. [in Russian]
10. Chapron C, Santulli P, Steuli I et al. Endometriosis: causes of pain. Int J Gynecol Obstet 2012; 119: S177.
11. Адамян Л.В. Эндометриоз: диагностика, лечение и реабилитация. Федеральные рекомендации по ведению больных. М., 2013. / Adamian L.V. Endometrioz: diagnostika, lechenie i reabilitatsiia. Federal'nye rekomendatsii po vedeniiu bol'nykh. M., 2013. [in Russian]
12. Carmona F, Chapron C, Martínez-Zamora MÁ. Ovarian endometrioma but not deep infiltrating endometriosis is associated with increased serum levels of interleukin-8 and interleukin-6. J Reprod Immunol 2012; 1–2: 80–6.
13. Nisenblat V, Bossuyt PM, Shaikh R. Blood biomarkers for the non-invasive diagnosis of endometriosis. Cochrane Database Syst Rev 2016; Issue 5.
14. Ognong-Boulemo A, Dohan A, Hoeffel C et al. Adnexal masses associated with peritoneal involvement: diagnosis with CT and MRI. Abdom Radiol (NY) 2017. [Epub ahead of print]
15. Kanté F, Belghiti J, Roseau G et al. Comparison of the accuracy of rectal endoscopic sonography and magnetic resonance imaging in the diagnosis of colorectal endometriosis. Gynecol Obstet Fertil Senol 2017; 3: 131–6.
16. Hoyos LR, Benacerraf B, Puscheck EE. Imaging in Endometriosis and Adenomyosis. Clin Obstet Gynecol 2017; 1: 27–37.
17. Hudelist G, Fritzer N, Thomas A et al. Diagnostic delay for endometriosis in Austria and Germany: causes and possible consequences. Hum Reprod 2012; 12: 3412–6.
18. Халимова Д.Р. Клинико-иммунологические особенности течения воспалительных заболеваний органов малого таза у девушек. Репродуктивное здоровье детей и подростков. 2011; 3: 51–60. / Khalimova D.R. Kliniko-immunologicheskie osobennosti techeniia vospalitel'nykh zabolevanii organov malogo taza u devushek. Reproduktivnoe zdorov'e detei i podrostkov. 2011; 3: 51–60. [in Russian]
19. Адамян Л.В., Сонова М.М., Логинова О.Н. и др. Сравнительный анализ эффективности диеногеста и лейпрорелина в комплексном лечении генитального эндометриоза. Проблемы репродукции. 2013; 4: 33–8. / Adamian L.V., Sonova M.M., Loginova O.N. i dr. Sravnitel'nyi analiz effektivnosti dienogesta i leiprorelina v kompleksnom lechenii genital'nogo endometrioza. Problemy reproduktsii. 2013; 4: 33–8. [in Russian]
20. Somigliana E, Berlanda N, Benaglia L. Surgical excision of endometriomas and ovarian reserve: a systematic review on serum antimüllerian hormone level modifications. Fertil Steril 2012; 6: 1531–8.
21. Garcia-Velasco JA, Somigliana E. Management of endometriomas in women requiring IVF: to touch or not to touch. Hum Reprod 2009; 3: 496–501.
22. Gelbaya TA, Gordts S, D'Hooghe T.M. Management of endometrioma prior to IVF: compliance with ESHRE guidelines. Reprod Biomed Online 2010; 3: 325–30.
23. Vercellini P, Frattaruolo MP, Somigliana E et al. Surgical versus low-dose progestin treatment for endometriosis-associated severe deep dyspareunia II: Effect on sexual functioning, psychological status and health-related quality of life. Hum Reprod 2013; 28 (5): 1221–30.
24. ACOG Practice Bulletin № 114. Management of endometriosis. Obstet Gynecol 2010; 116: 223–36.
25. Falcone T, Lebovic DI. Clinical management of endometriosis. Obstet Gynecol 2011; 118 (3): 691–705.
26. Leyland N, Casper R, Laberge Ph et al. Endometriosis: Diagnosis and Management. Clinical Practice Guideline. JOGC 2010; 32 (7): 1–27.
27. Vercellini P, Crosignani PG, Somigliana E et al. “Waiting for Godot”: a commonsense approach to the medical treatment of endometriosis. Hum Reprod 2011; 26 (1): 3–13.
28. Allen C, Hopewell S, Prentice A, Gregory D. Nonsteroidal anti-inflammatory drugs for pain in women with endometriosis. Cochrane Database Syst Rev 2009; 2: CD004753.
29. Каратеев А.Е., Яхно Н.Н., Лазебник Л.Б. и др. Применение нестероидных противовоспалительных препаратов. Клинические рекомендации. М.: ИМА-ПРЕСС, 2009; с. 9. / Karateev A.E., Iakhno N.N., Lazebnik L.B. i dr. Primenenie nesteroidnykh protivovospalitel'nykh preparatov. Klinicheskie rekomendatsii. M.: IMA-PRESS, 2009; s. 9. [in Russian]
30. Caruso S, Iraci M, Cianci S et al. Comparative, open-label prospective study on the quality of life and sexual function of women affected by endometriosis-associated pelvic pain on 2 mg dienogest/30 µg ethinyl estradiol continuous or 21/7 regimen oral contraceptive. J Endocrinol Invest 2016; 8: 923–31.
31. Matsuzaki S, Canis M, Pouly J-L et al. Both GnRH agonist and continuous oral progestin treatments reduce the expression of the tyrosine kinase receptor B and mu-opioid receptor in deep infiltrating endometriosis. Hum Reprod 2007; 22 (1): 124–8.
32. Атаманчук И.Н. Гормональная контрацепция при эндометриозе. Мед. аспекты здоровья женщины. 2014; 7: 5–11. / Atamanchuk I.N. Gormonal'naia kontratseptsiia pri endometrioze. Med. aspekty zdorov'ia zhenshchiny. 2014; 7: 5–11. [in Russian]
33. Hughes E, Brown J, Collins JJ et al. Ovulation suppression for endometriosis. Cochrane Database Syst Rev 2007; 3: CD000155.
34. Harada T, Momoeda M, Taketani Y et al. Dienogest is as effective as intranasal busereline acetate for the relief of pain symptoms associated with endometriosis – a randomized, double-blind, multicenter, controlled trial. Fertil Steril 2009; 91 (3): 774–80.
35. Davis LJ, Kennedy SS, Moore J, Prentice A. Oral contraceptives for pain associated with endometriosis. Cochrane Database Syst Rev 2007; 3: CD001019.
36. Cheong Y, Tay P, Luk F et al. Laparoscopic surgery for endometriosis: how often do we need to reoperate? J Obstet Gynecol 2008; 28: 82–5.
37. Shakiba K, Bena JF, McGill KM et al. Surgical treatment of endometriosis: a 7-year follow up on the requirement for further surgery. Obstet Gynecol 2008; 111: 1285–92.
38. Harada T, Momoeda M, Taketani Y, Terekawa N. Low-dose oral contraceptive pill for dysmenorrhea associated with endometriosis: a placebo-controlled, double-blind, randomized trial. Fertil Steril 2008; 90: 1583–8.
39. Vercellini P, Somigliana E, Viganò P et al. Endometriosis: current and future medical therapies. Best Pract Res Clin Obstet Gynaecol 2008; 22: 275–306.
40. Somigliana E, Busnelli A, Benaglia L et al. Postoperative hormonal therapy after surgical excision of deep endometriosis. Eur J Obstet Gynecol Reprod Biol 2017; 209: 77–80.
41. Vercellini P, Somigliana E, Viganò P et al. Post-operative endometriosis recurrence: a plea for prevention based on pathogenetic, epidemiological and clinical evidence. Reprod Biomed Online 2010; 2: 259–65.
42. Harada T, Momoeda M, Terekawa N et al. Evaluation of a low-dose oral contraceptive pill for primary dysmenorrheal: a placebo-controlled, double-blind, randomized trial. Fertil Steril 2011; 95: 1928–31.
43. Taran FA, Stewart EA, Brucker S. Adenomyosis: Epidemiology, Risk Factors, Clinical Phenotype and Surgical and Interventional Alternatives to Hysterectomy. Geburtshilfe Frauenheilkd 2013; 9: 924–31.
44. Сперофф Л., Дарни Ф.Д. Клиническое руководство по контрацепции. Пер с англ. М.: БИНОМ, 2009. / Speroff L., Darni F.D. Klinicheskoe rukovodstvo po kontratseptsii. Per s angl. M.: BINOM, 2009. [in Russian]
45. Schindler AE. Non-contraceptive benefits of oral hormonal contraceptives. Int J Endocrinol Metab 2013; 1: 41–7.
46. Global Consensus of World Endometriosis Society. Montpellier. 25.03.2013.
47. Schweppe K-W. Long-term use of progestogens – effects on endometriosis, adenomiosis and myomas. Gynecol Endocrinol 2007; 23 (S1): 17–21.
48. Grandi G, Mueller M, Bersinger NA et al. Does dienogest influence the inflammatory response of endometriotic cells? A systematic review. Inflamm Res 2016; 3: 183–92.
49. Iacovides S, Avidon I, Baker FC. What we know about primary dysmenorrhea today: a critical review. Hum Reprod Update 2015; 6: 762–78.
50. Leonardo-Pinto JP, Benetti-Pinto CL, Cursino K. Dienogest and deep infiltrating endometriosis: The remission of symptoms is not related to endometriosis nodule remission. Eur J Obstet Gynecol Reprod Biol 2017; p. 108–11.
51. Zito G, Luppi S, Giolo E et al. Medical treatments for endometriosis-associated pelvic pain. Biomed Res Int 2014; p. 191–967.
2. Vorob'eva O.V. Khronicheskie tazovye boli: fokus na miofastsial'nyi bolevoi sindrom myshts tazovogo dna. Consilium Medicum. 2012; 6 (14): 14–8. [in Russian]
3. Adamian L.V., Sukhikh G.T. Tekhnologii XXI veka v ginekologii. M.: Mediasfera, 2008; s. 248. [in Russian]
4. Coosemans A, Moerman P, Vergote I et al. Wilm`s tumor gene 1(WT1) over expression in neurons in deep endometriosis: a pilot study. Fertil Steril 2009; 91 (4): 1441–4.
5. Giamberardino MA. Women and visceral pain: are the reproductive organs the main protagonists? Minireview at the occasion of the “European week against pain in women 2007”. Eur J Pain 2008; 12 (3): 257–60.
6. Wiech K, Tracey I. Influence of negative emotions on pain: behavioral effects and neural mechanisms. Neuroimage 2009; 47: 987–94.
7. Craig KD, Versloot J, Goubert L et al. Perceiving pain in others: automatic and controlled mechanisms. Pain 2010; 11 (2): 101–8.
8. Yarell J, Giamberardino MA, Robert M, Nasr-Esfabani M. Bed-side testing for chronic pelvic pain: discriminating visceral from somatic pain. Pain Res Treat 2011; 11: 692–8.
9. Adamian L.V., Sonova M.M., Tikhonova E.S. i dr. Meditsinskie i sotsial'nye aspekty genital'nogo endometrioza. Problemy reproduktsii. 2011; 6: 78–81. [in Russian]
10. Chapron C, Santulli P, Steuli I et al. Endometriosis: causes of pain. Int J Gynecol Obstet 2012; 119: S177.
11. Adamian L.V. Endometrioz: diagnostika, lechenie i reabilitatsiia. Federal'nye rekomendatsii po vedeniiu bol'nykh. M., 2013. [in Russian]
12. Carmona F, Chapron C, Martínez-Zamora MÁ. Ovarian endometrioma but not deep infiltrating endometriosis is associated with increased serum levels of interleukin-8 and interleukin-6. J Reprod Immunol 2012; 1–2: 80–6.
13. Nisenblat V, Bossuyt PM, Shaikh R. Blood biomarkers for the non-invasive diagnosis of endometriosis. Cochrane Database Syst Rev 2016; Issue 5.
14. Ognong-Boulemo A, Dohan A, Hoeffel C et al. Adnexal masses associated with peritoneal involvement: diagnosis with CT and MRI. Abdom Radiol (NY) 2017. [Epub ahead of print]
15. Kanté F, Belghiti J, Roseau G et al. Comparison of the accuracy of rectal endoscopic sonography and magnetic resonance imaging in the diagnosis of colorectal endometriosis. Gynecol Obstet Fertil Senol 2017; 3: 131–6.
16. Hoyos LR, Benacerraf B, Puscheck EE. Imaging in Endometriosis and Adenomyosis. Clin Obstet Gynecol 2017; 1: 27–37.
17. Hudelist G, Fritzer N, Thomas A et al. Diagnostic delay for endometriosis in Austria and Germany: causes and possible consequences. Hum Reprod 2012; 12: 3412–6.
18. Khalimova D.R. Kliniko-immunologicheskie osobennosti techeniia vospalitel'nykh zabolevanii organov malogo taza u devushek. Reproduktivnoe zdorov'e detei i podrostkov. 2011; 3: 51–60. [in Russian]
19. Adamian L.V., Sonova M.M., Loginova O.N. i dr. Sravnitel'nyi analiz effektivnosti dienogesta i leiprorelina v kompleksnom lechenii genital'nogo endometrioza. Problemy reproduktsii. 2013; 4: 33–8. [in Russian]
20. Somigliana E, Berlanda N, Benaglia L. Surgical excision of endometriomas and ovarian reserve: a systematic review on serum antimüllerian hormone level modifications. Fertil Steril 2012; 6: 1531–8.
21. Garcia-Velasco JA, Somigliana E. Management of endometriomas in women requiring IVF: to touch or not to touch. Hum Reprod 2009; 3: 496–501.
22. Gelbaya TA, Gordts S, D'Hooghe T.M. Management of endometrioma prior to IVF: compliance with ESHRE guidelines. Reprod Biomed Online 2010; 3: 325–30.
23. Vercellini P, Frattaruolo MP, Somigliana E et al. Surgical versus low-dose progestin treatment for endometriosis-associated severe deep dyspareunia II: Effect on sexual functioning, psychological status and health-related quality of life. Hum Reprod 2013; 28 (5): 1221–30.
24. ACOG Practice Bulletin № 114. Management of endometriosis. Obstet Gynecol 2010; 116: 223–36.
25. Falcone T, Lebovic DI. Clinical management of endometriosis. Obstet Gynecol 2011; 118 (3): 691–705.
26. Leyland N, Casper R, Laberge Ph et al. Endometriosis: Diagnosis and Management. Clinical Practice Guideline. JOGC 2010; 32 (7): 1–27.
27. Vercellini P, Crosignani PG, Somigliana E et al. “Waiting for Godot”: a commonsense approach to the medical treatment of endometriosis. Hum Reprod 2011; 26 (1): 3–13.
28. Allen C, Hopewell S, Prentice A, Gregory D. Nonsteroidal anti-inflammatory drugs for pain in women with endometriosis. Cochrane Database Syst Rev 2009; 2: CD004753.
29. Karateev A.E., Iakhno N.N., Lazebnik L.B. i dr. Primenenie nesteroidnykh protivovospalitel'nykh preparatov. Klinicheskie rekomendatsii. M.: IMA-PRESS, 2009; s. 9. [in Russian]
30. Caruso S, Iraci M, Cianci S et al. Comparative, open-label prospective study on the quality of life and sexual function of women affected by endometriosis-associated pelvic pain on 2 mg dienogest/30 µg ethinyl estradiol continuous or 21/7 regimen oral contraceptive. J Endocrinol Invest 2016; 8: 923–31.
31. Matsuzaki S, Canis M, Pouly J-L et al. Both GnRH agonist and continuous oral progestin treatments reduce the expression of the tyrosine kinase receptor B and mu-opioid receptor in deep infiltrating endometriosis. Hum Reprod 2007; 22 (1): 124–8.
32. Atamanchuk I.N. Gormonal'naia kontratseptsiia pri endometrioze. Med. aspekty zdorov'ia zhenshchiny. 2014; 7: 5–11. [in Russian]
33. Hughes E, Brown J, Collins JJ et al. Ovulation suppression for endometriosis. Cochrane Database Syst Rev 2007; 3: CD000155.
34. Harada T, Momoeda M, Taketani Y et al. Dienogest is as effective as intranasal busereline acetate for the relief of pain symptoms associated with endometriosis – a randomized, double-blind, multicenter, controlled trial. Fertil Steril 2009; 91 (3): 774–80.
35. Davis LJ, Kennedy SS, Moore J, Prentice A. Oral contraceptives for pain associated with endometriosis. Cochrane Database Syst Rev 2007; 3: CD001019.
36. Cheong Y, Tay P, Luk F et al. Laparoscopic surgery for endometriosis: how often do we need to reoperate? J Obstet Gynecol 2008; 28: 82–5.
37. Shakiba K, Bena JF, McGill KM et al. Surgical treatment of endometriosis: a 7-year follow up on the requirement for further surgery. Obstet Gynecol 2008; 111: 1285–92.
38. Harada T, Momoeda M, Taketani Y, Terekawa N. Low-dose oral contraceptive pill for dysmenorrhea associated with endometriosis: a placebo-controlled, double-blind, randomized trial. Fertil Steril 2008; 90: 1583–8.
39. Vercellini P, Somigliana E, Viganò P et al. Endometriosis: current and future medical therapies. Best Pract Res Clin Obstet Gynaecol 2008; 22: 275–306.
40. Somigliana E, Busnelli A, Benaglia L et al. Postoperative hormonal therapy after surgical excision of deep endometriosis. Eur J Obstet Gynecol Reprod Biol 2017; 209: 77–80.
41. Vercellini P, Somigliana E, Viganò P et al. Post-operative endometriosis recurrence: a plea for prevention based on pathogenetic, epidemiological and clinical evidence. Reprod Biomed Online 2010; 2: 259–65.
42. Harada T, Momoeda M, Terekawa N et al. Evaluation of a low-dose oral contraceptive pill for primary dysmenorrheal: a placebo-controlled, double-blind, randomized trial. Fertil Steril 2011; 95: 1928–31.
43. Taran FA, Stewart EA, Brucker S. Adenomyosis: Epidemiology, Risk Factors, Clinical Phenotype and Surgical and Interventional Alternatives to Hysterectomy. Geburtshilfe Frauenheilkd 2013; 9: 924–31.
44. Speroff L., Darni F.D. Klinicheskoe rukovodstvo po kontratseptsii. Per s angl. M.: BINOM, 2009. [in Russian]
45. Schindler AE. Non-contraceptive benefits of oral hormonal contraceptives. Int J Endocrinol Metab 2013; 1: 41–7.
46. Global Consensus of World Endometriosis Society. Montpellier. 25.03.2013.
47. Schweppe K-W. Long-term use of progestogens – effects on endometriosis, adenomiosis and myomas. Gynecol Endocrinol 2007; 23 (S1): 17–21.
48. Grandi G, Mueller M, Bersinger NA et al. Does dienogest influence the inflammatory response of endometriotic cells? A systematic review. Inflamm Res 2016; 3: 183–92.
49. Iacovides S, Avidon I, Baker FC. What we know about primary dysmenorrhea today: a critical review. Hum Reprod Update 2015; 6: 762–78.
50. Leonardo-Pinto JP, Benetti-Pinto CL, Cursino K. Dienogest and deep infiltrating endometriosis: The remission of symptoms is not related to endometriosis nodule remission. Eur J Obstet Gynecol Reprod Biol 2017; p. 108–11.
51. Zito G, Luppi S, Giolo E et al. Medical treatments for endometriosis-associated pelvic pain. Biomed Res Int 2014; p. 191–967.
2. Воробьева О.В. Хронические тазовые боли: фокус на миофасциальный болевой синдром мышц тазового дна. Consilium Medicum. 2012; 6 (14): 14–8. / Vorob'eva O.V. Khronicheskie tazovye boli: fokus na miofastsial'nyi bolevoi sindrom myshts tazovogo dna. Consilium Medicum. 2012; 6 (14): 14–8. [in Russian]
3. Адамян Л.В., Сухих Г.Т. Технологии XXI века в гинекологии. М.: Медиасфера, 2008; с. 248. / Adamian L.V., Sukhikh G.T. Tekhnologii XXI veka v ginekologii. M.: Mediasfera, 2008; s. 248. [in Russian]
4. Coosemans A, Moerman P, Vergote I et al. Wilm`s tumor gene 1(WT1) over expression in neurons in deep endometriosis: a pilot study. Fertil Steril 2009; 91 (4): 1441–4.
5. Giamberardino MA. Women and visceral pain: are the reproductive organs the main protagonists? Minireview at the occasion of the “European week against pain in women 2007”. Eur J Pain 2008; 12 (3): 257–60.
6. Wiech K, Tracey I. Influence of negative emotions on pain: behavioral effects and neural mechanisms. Neuroimage 2009; 47: 987–94.
7. Craig KD, Versloot J, Goubert L et al. Perceiving pain in others: automatic and controlled mechanisms. Pain 2010; 11 (2): 101–8.
8. Yarell J, Giamberardino MA, Robert M, Nasr-Esfabani M. Bed-side testing for chronic pelvic pain: discriminating visceral from somatic pain. Pain Res Treat 2011; 11: 692–8.
9. Адамян Л.В., Сонова М.М., Тихонова Е.С. и др. Медицинские и социальные аспекты генитального эндометриоза. Проблемы репродукции. 2011; 6: 78–81. / Adamian L.V., Sonova M.M., Tikhonova E.S. i dr. Meditsinskie i sotsial'nye aspekty genital'nogo endometrioza. Problemy reproduktsii. 2011; 6: 78–81. [in Russian]
10. Chapron C, Santulli P, Steuli I et al. Endometriosis: causes of pain. Int J Gynecol Obstet 2012; 119: S177.
11. Адамян Л.В. Эндометриоз: диагностика, лечение и реабилитация. Федеральные рекомендации по ведению больных. М., 2013. / Adamian L.V. Endometrioz: diagnostika, lechenie i reabilitatsiia. Federal'nye rekomendatsii po vedeniiu bol'nykh. M., 2013. [in Russian]
12. Carmona F, Chapron C, Martínez-Zamora MÁ. Ovarian endometrioma but not deep infiltrating endometriosis is associated with increased serum levels of interleukin-8 and interleukin-6. J Reprod Immunol 2012; 1–2: 80–6.
13. Nisenblat V, Bossuyt PM, Shaikh R. Blood biomarkers for the non-invasive diagnosis of endometriosis. Cochrane Database Syst Rev 2016; Issue 5.
14. Ognong-Boulemo A, Dohan A, Hoeffel C et al. Adnexal masses associated with peritoneal involvement: diagnosis with CT and MRI. Abdom Radiol (NY) 2017. [Epub ahead of print]
15. Kanté F, Belghiti J, Roseau G et al. Comparison of the accuracy of rectal endoscopic sonography and magnetic resonance imaging in the diagnosis of colorectal endometriosis. Gynecol Obstet Fertil Senol 2017; 3: 131–6.
16. Hoyos LR, Benacerraf B, Puscheck EE. Imaging in Endometriosis and Adenomyosis. Clin Obstet Gynecol 2017; 1: 27–37.
17. Hudelist G, Fritzer N, Thomas A et al. Diagnostic delay for endometriosis in Austria and Germany: causes and possible consequences. Hum Reprod 2012; 12: 3412–6.
18. Халимова Д.Р. Клинико-иммунологические особенности течения воспалительных заболеваний органов малого таза у девушек. Репродуктивное здоровье детей и подростков. 2011; 3: 51–60. / Khalimova D.R. Kliniko-immunologicheskie osobennosti techeniia vospalitel'nykh zabolevanii organov malogo taza u devushek. Reproduktivnoe zdorov'e detei i podrostkov. 2011; 3: 51–60. [in Russian]
19. Адамян Л.В., Сонова М.М., Логинова О.Н. и др. Сравнительный анализ эффективности диеногеста и лейпрорелина в комплексном лечении генитального эндометриоза. Проблемы репродукции. 2013; 4: 33–8. / Adamian L.V., Sonova M.M., Loginova O.N. i dr. Sravnitel'nyi analiz effektivnosti dienogesta i leiprorelina v kompleksnom lechenii genital'nogo endometrioza. Problemy reproduktsii. 2013; 4: 33–8. [in Russian]
20. Somigliana E, Berlanda N, Benaglia L. Surgical excision of endometriomas and ovarian reserve: a systematic review on serum antimüllerian hormone level modifications. Fertil Steril 2012; 6: 1531–8.
21. Garcia-Velasco JA, Somigliana E. Management of endometriomas in women requiring IVF: to touch or not to touch. Hum Reprod 2009; 3: 496–501.
22. Gelbaya TA, Gordts S, D'Hooghe T.M. Management of endometrioma prior to IVF: compliance with ESHRE guidelines. Reprod Biomed Online 2010; 3: 325–30.
23. Vercellini P, Frattaruolo MP, Somigliana E et al. Surgical versus low-dose progestin treatment for endometriosis-associated severe deep dyspareunia II: Effect on sexual functioning, psychological status and health-related quality of life. Hum Reprod 2013; 28 (5): 1221–30.
24. ACOG Practice Bulletin № 114. Management of endometriosis. Obstet Gynecol 2010; 116: 223–36.
25. Falcone T, Lebovic DI. Clinical management of endometriosis. Obstet Gynecol 2011; 118 (3): 691–705.
26. Leyland N, Casper R, Laberge Ph et al. Endometriosis: Diagnosis and Management. Clinical Practice Guideline. JOGC 2010; 32 (7): 1–27.
27. Vercellini P, Crosignani PG, Somigliana E et al. “Waiting for Godot”: a commonsense approach to the medical treatment of endometriosis. Hum Reprod 2011; 26 (1): 3–13.
28. Allen C, Hopewell S, Prentice A, Gregory D. Nonsteroidal anti-inflammatory drugs for pain in women with endometriosis. Cochrane Database Syst Rev 2009; 2: CD004753.
29. Каратеев А.Е., Яхно Н.Н., Лазебник Л.Б. и др. Применение нестероидных противовоспалительных препаратов. Клинические рекомендации. М.: ИМА-ПРЕСС, 2009; с. 9. / Karateev A.E., Iakhno N.N., Lazebnik L.B. i dr. Primenenie nesteroidnykh protivovospalitel'nykh preparatov. Klinicheskie rekomendatsii. M.: IMA-PRESS, 2009; s. 9. [in Russian]
30. Caruso S, Iraci M, Cianci S et al. Comparative, open-label prospective study on the quality of life and sexual function of women affected by endometriosis-associated pelvic pain on 2 mg dienogest/30 µg ethinyl estradiol continuous or 21/7 regimen oral contraceptive. J Endocrinol Invest 2016; 8: 923–31.
31. Matsuzaki S, Canis M, Pouly J-L et al. Both GnRH agonist and continuous oral progestin treatments reduce the expression of the tyrosine kinase receptor B and mu-opioid receptor in deep infiltrating endometriosis. Hum Reprod 2007; 22 (1): 124–8.
32. Атаманчук И.Н. Гормональная контрацепция при эндометриозе. Мед. аспекты здоровья женщины. 2014; 7: 5–11. / Atamanchuk I.N. Gormonal'naia kontratseptsiia pri endometrioze. Med. aspekty zdorov'ia zhenshchiny. 2014; 7: 5–11. [in Russian]
33. Hughes E, Brown J, Collins JJ et al. Ovulation suppression for endometriosis. Cochrane Database Syst Rev 2007; 3: CD000155.
34. Harada T, Momoeda M, Taketani Y et al. Dienogest is as effective as intranasal busereline acetate for the relief of pain symptoms associated with endometriosis – a randomized, double-blind, multicenter, controlled trial. Fertil Steril 2009; 91 (3): 774–80.
35. Davis LJ, Kennedy SS, Moore J, Prentice A. Oral contraceptives for pain associated with endometriosis. Cochrane Database Syst Rev 2007; 3: CD001019.
36. Cheong Y, Tay P, Luk F et al. Laparoscopic surgery for endometriosis: how often do we need to reoperate? J Obstet Gynecol 2008; 28: 82–5.
37. Shakiba K, Bena JF, McGill KM et al. Surgical treatment of endometriosis: a 7-year follow up on the requirement for further surgery. Obstet Gynecol 2008; 111: 1285–92.
38. Harada T, Momoeda M, Taketani Y, Terekawa N. Low-dose oral contraceptive pill for dysmenorrhea associated with endometriosis: a placebo-controlled, double-blind, randomized trial. Fertil Steril 2008; 90: 1583–8.
39. Vercellini P, Somigliana E, Viganò P et al. Endometriosis: current and future medical therapies. Best Pract Res Clin Obstet Gynaecol 2008; 22: 275–306.
40. Somigliana E, Busnelli A, Benaglia L et al. Postoperative hormonal therapy after surgical excision of deep endometriosis. Eur J Obstet Gynecol Reprod Biol 2017; 209: 77–80.
41. Vercellini P, Somigliana E, Viganò P et al. Post-operative endometriosis recurrence: a plea for prevention based on pathogenetic, epidemiological and clinical evidence. Reprod Biomed Online 2010; 2: 259–65.
42. Harada T, Momoeda M, Terekawa N et al. Evaluation of a low-dose oral contraceptive pill for primary dysmenorrheal: a placebo-controlled, double-blind, randomized trial. Fertil Steril 2011; 95: 1928–31.
43. Taran FA, Stewart EA, Brucker S. Adenomyosis: Epidemiology, Risk Factors, Clinical Phenotype and Surgical and Interventional Alternatives to Hysterectomy. Geburtshilfe Frauenheilkd 2013; 9: 924–31.
44. Сперофф Л., Дарни Ф.Д. Клиническое руководство по контрацепции. Пер с англ. М.: БИНОМ, 2009. / Speroff L., Darni F.D. Klinicheskoe rukovodstvo po kontratseptsii. Per s angl. M.: BINOM, 2009. [in Russian]
45. Schindler AE. Non-contraceptive benefits of oral hormonal contraceptives. Int J Endocrinol Metab 2013; 1: 41–7.
46. Global Consensus of World Endometriosis Society. Montpellier. 25.03.2013.
47. Schweppe K-W. Long-term use of progestogens – effects on endometriosis, adenomiosis and myomas. Gynecol Endocrinol 2007; 23 (S1): 17–21.
48. Grandi G, Mueller M, Bersinger NA et al. Does dienogest influence the inflammatory response of endometriotic cells? A systematic review. Inflamm Res 2016; 3: 183–92.
49. Iacovides S, Avidon I, Baker FC. What we know about primary dysmenorrhea today: a critical review. Hum Reprod Update 2015; 6: 762–78.
50. Leonardo-Pinto JP, Benetti-Pinto CL, Cursino K. Dienogest and deep infiltrating endometriosis: The remission of symptoms is not related to endometriosis nodule remission. Eur J Obstet Gynecol Reprod Biol 2017; p. 108–11.
51. Zito G, Luppi S, Giolo E et al. Medical treatments for endometriosis-associated pelvic pain. Biomed Res Int 2014; p. 191–967.
________________________________________________
2. Vorob'eva O.V. Khronicheskie tazovye boli: fokus na miofastsial'nyi bolevoi sindrom myshts tazovogo dna. Consilium Medicum. 2012; 6 (14): 14–8. [in Russian]
3. Adamian L.V., Sukhikh G.T. Tekhnologii XXI veka v ginekologii. M.: Mediasfera, 2008; s. 248. [in Russian]
4. Coosemans A, Moerman P, Vergote I et al. Wilm`s tumor gene 1(WT1) over expression in neurons in deep endometriosis: a pilot study. Fertil Steril 2009; 91 (4): 1441–4.
5. Giamberardino MA. Women and visceral pain: are the reproductive organs the main protagonists? Minireview at the occasion of the “European week against pain in women 2007”. Eur J Pain 2008; 12 (3): 257–60.
6. Wiech K, Tracey I. Influence of negative emotions on pain: behavioral effects and neural mechanisms. Neuroimage 2009; 47: 987–94.
7. Craig KD, Versloot J, Goubert L et al. Perceiving pain in others: automatic and controlled mechanisms. Pain 2010; 11 (2): 101–8.
8. Yarell J, Giamberardino MA, Robert M, Nasr-Esfabani M. Bed-side testing for chronic pelvic pain: discriminating visceral from somatic pain. Pain Res Treat 2011; 11: 692–8.
9. Adamian L.V., Sonova M.M., Tikhonova E.S. i dr. Meditsinskie i sotsial'nye aspekty genital'nogo endometrioza. Problemy reproduktsii. 2011; 6: 78–81. [in Russian]
10. Chapron C, Santulli P, Steuli I et al. Endometriosis: causes of pain. Int J Gynecol Obstet 2012; 119: S177.
11. Adamian L.V. Endometrioz: diagnostika, lechenie i reabilitatsiia. Federal'nye rekomendatsii po vedeniiu bol'nykh. M., 2013. [in Russian]
12. Carmona F, Chapron C, Martínez-Zamora MÁ. Ovarian endometrioma but not deep infiltrating endometriosis is associated with increased serum levels of interleukin-8 and interleukin-6. J Reprod Immunol 2012; 1–2: 80–6.
13. Nisenblat V, Bossuyt PM, Shaikh R. Blood biomarkers for the non-invasive diagnosis of endometriosis. Cochrane Database Syst Rev 2016; Issue 5.
14. Ognong-Boulemo A, Dohan A, Hoeffel C et al. Adnexal masses associated with peritoneal involvement: diagnosis with CT and MRI. Abdom Radiol (NY) 2017. [Epub ahead of print]
15. Kanté F, Belghiti J, Roseau G et al. Comparison of the accuracy of rectal endoscopic sonography and magnetic resonance imaging in the diagnosis of colorectal endometriosis. Gynecol Obstet Fertil Senol 2017; 3: 131–6.
16. Hoyos LR, Benacerraf B, Puscheck EE. Imaging in Endometriosis and Adenomyosis. Clin Obstet Gynecol 2017; 1: 27–37.
17. Hudelist G, Fritzer N, Thomas A et al. Diagnostic delay for endometriosis in Austria and Germany: causes and possible consequences. Hum Reprod 2012; 12: 3412–6.
18. Khalimova D.R. Kliniko-immunologicheskie osobennosti techeniia vospalitel'nykh zabolevanii organov malogo taza u devushek. Reproduktivnoe zdorov'e detei i podrostkov. 2011; 3: 51–60. [in Russian]
19. Adamian L.V., Sonova M.M., Loginova O.N. i dr. Sravnitel'nyi analiz effektivnosti dienogesta i leiprorelina v kompleksnom lechenii genital'nogo endometrioza. Problemy reproduktsii. 2013; 4: 33–8. [in Russian]
20. Somigliana E, Berlanda N, Benaglia L. Surgical excision of endometriomas and ovarian reserve: a systematic review on serum antimüllerian hormone level modifications. Fertil Steril 2012; 6: 1531–8.
21. Garcia-Velasco JA, Somigliana E. Management of endometriomas in women requiring IVF: to touch or not to touch. Hum Reprod 2009; 3: 496–501.
22. Gelbaya TA, Gordts S, D'Hooghe T.M. Management of endometrioma prior to IVF: compliance with ESHRE guidelines. Reprod Biomed Online 2010; 3: 325–30.
23. Vercellini P, Frattaruolo MP, Somigliana E et al. Surgical versus low-dose progestin treatment for endometriosis-associated severe deep dyspareunia II: Effect on sexual functioning, psychological status and health-related quality of life. Hum Reprod 2013; 28 (5): 1221–30.
24. ACOG Practice Bulletin № 114. Management of endometriosis. Obstet Gynecol 2010; 116: 223–36.
25. Falcone T, Lebovic DI. Clinical management of endometriosis. Obstet Gynecol 2011; 118 (3): 691–705.
26. Leyland N, Casper R, Laberge Ph et al. Endometriosis: Diagnosis and Management. Clinical Practice Guideline. JOGC 2010; 32 (7): 1–27.
27. Vercellini P, Crosignani PG, Somigliana E et al. “Waiting for Godot”: a commonsense approach to the medical treatment of endometriosis. Hum Reprod 2011; 26 (1): 3–13.
28. Allen C, Hopewell S, Prentice A, Gregory D. Nonsteroidal anti-inflammatory drugs for pain in women with endometriosis. Cochrane Database Syst Rev 2009; 2: CD004753.
29. Karateev A.E., Iakhno N.N., Lazebnik L.B. i dr. Primenenie nesteroidnykh protivovospalitel'nykh preparatov. Klinicheskie rekomendatsii. M.: IMA-PRESS, 2009; s. 9. [in Russian]
30. Caruso S, Iraci M, Cianci S et al. Comparative, open-label prospective study on the quality of life and sexual function of women affected by endometriosis-associated pelvic pain on 2 mg dienogest/30 µg ethinyl estradiol continuous or 21/7 regimen oral contraceptive. J Endocrinol Invest 2016; 8: 923–31.
31. Matsuzaki S, Canis M, Pouly J-L et al. Both GnRH agonist and continuous oral progestin treatments reduce the expression of the tyrosine kinase receptor B and mu-opioid receptor in deep infiltrating endometriosis. Hum Reprod 2007; 22 (1): 124–8.
32. Atamanchuk I.N. Gormonal'naia kontratseptsiia pri endometrioze. Med. aspekty zdorov'ia zhenshchiny. 2014; 7: 5–11. [in Russian]
33. Hughes E, Brown J, Collins JJ et al. Ovulation suppression for endometriosis. Cochrane Database Syst Rev 2007; 3: CD000155.
34. Harada T, Momoeda M, Taketani Y et al. Dienogest is as effective as intranasal busereline acetate for the relief of pain symptoms associated with endometriosis – a randomized, double-blind, multicenter, controlled trial. Fertil Steril 2009; 91 (3): 774–80.
35. Davis LJ, Kennedy SS, Moore J, Prentice A. Oral contraceptives for pain associated with endometriosis. Cochrane Database Syst Rev 2007; 3: CD001019.
36. Cheong Y, Tay P, Luk F et al. Laparoscopic surgery for endometriosis: how often do we need to reoperate? J Obstet Gynecol 2008; 28: 82–5.
37. Shakiba K, Bena JF, McGill KM et al. Surgical treatment of endometriosis: a 7-year follow up on the requirement for further surgery. Obstet Gynecol 2008; 111: 1285–92.
38. Harada T, Momoeda M, Taketani Y, Terekawa N. Low-dose oral contraceptive pill for dysmenorrhea associated with endometriosis: a placebo-controlled, double-blind, randomized trial. Fertil Steril 2008; 90: 1583–8.
39. Vercellini P, Somigliana E, Viganò P et al. Endometriosis: current and future medical therapies. Best Pract Res Clin Obstet Gynaecol 2008; 22: 275–306.
40. Somigliana E, Busnelli A, Benaglia L et al. Postoperative hormonal therapy after surgical excision of deep endometriosis. Eur J Obstet Gynecol Reprod Biol 2017; 209: 77–80.
41. Vercellini P, Somigliana E, Viganò P et al. Post-operative endometriosis recurrence: a plea for prevention based on pathogenetic, epidemiological and clinical evidence. Reprod Biomed Online 2010; 2: 259–65.
42. Harada T, Momoeda M, Terekawa N et al. Evaluation of a low-dose oral contraceptive pill for primary dysmenorrheal: a placebo-controlled, double-blind, randomized trial. Fertil Steril 2011; 95: 1928–31.
43. Taran FA, Stewart EA, Brucker S. Adenomyosis: Epidemiology, Risk Factors, Clinical Phenotype and Surgical and Interventional Alternatives to Hysterectomy. Geburtshilfe Frauenheilkd 2013; 9: 924–31.
44. Speroff L., Darni F.D. Klinicheskoe rukovodstvo po kontratseptsii. Per s angl. M.: BINOM, 2009. [in Russian]
45. Schindler AE. Non-contraceptive benefits of oral hormonal contraceptives. Int J Endocrinol Metab 2013; 1: 41–7.
46. Global Consensus of World Endometriosis Society. Montpellier. 25.03.2013.
47. Schweppe K-W. Long-term use of progestogens – effects on endometriosis, adenomiosis and myomas. Gynecol Endocrinol 2007; 23 (S1): 17–21.
48. Grandi G, Mueller M, Bersinger NA et al. Does dienogest influence the inflammatory response of endometriotic cells? A systematic review. Inflamm Res 2016; 3: 183–92.
49. Iacovides S, Avidon I, Baker FC. What we know about primary dysmenorrhea today: a critical review. Hum Reprod Update 2015; 6: 762–78.
50. Leonardo-Pinto JP, Benetti-Pinto CL, Cursino K. Dienogest and deep infiltrating endometriosis: The remission of symptoms is not related to endometriosis nodule remission. Eur J Obstet Gynecol Reprod Biol 2017; p. 108–11.
51. Zito G, Luppi S, Giolo E et al. Medical treatments for endometriosis-associated pelvic pain. Biomed Res Int 2014; p. 191–967.
Авторы
И.В.Кузнецова*
ФГАОУ ВО «Первый Московский государственный медицинский университет им. И.М.Сеченова» Минздрава России. 119991, Россия, Москва, ул. Трубецкая, д. 8, стр. 2
*ms.smith.ivk@gmail.com
I.M.Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation. 119991, Russian Federation, Moscow, ul. Trubetskaia, d. 8, str. 2
*ms.smith.ivk@gmail.com
ФГАОУ ВО «Первый Московский государственный медицинский университет им. И.М.Сеченова» Минздрава России. 119991, Россия, Москва, ул. Трубецкая, д. 8, стр. 2
*ms.smith.ivk@gmail.com
________________________________________________
I.M.Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation. 119991, Russian Federation, Moscow, ul. Trubetskaia, d. 8, str. 2
*ms.smith.ivk@gmail.com
Цель портала OmniDoctor – предоставление профессиональной информации врачам, провизорам и фармацевтам.